Clinical Trial Update: Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Ex-vivo Antitubercular Activity of PBTZ169 Formulation [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacokinetics and ex-vivo antitubercular activity of the PBTZ169 formulation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis
• Tuberculosis

Drugs mentioned

• PBTZ169 (PBTZ169)

Snippet

Sponsor: Innovative Medicines for Tuberculosis | Conditions: Tuberculosis, Tuberculosis, Pulmonary | Phase 1 | Status: COMPLETED